Longbow Capital, Inc.
Longbow Capital is a private equity firm based in New York, established over 25 years ago. The firm has a strong focus on energy investments, leveraging a team with extensive industry experience and a network of global relationships. They specialize in transforming the way energy is produced and consumed, with a commitment to environmental responsibility. The team includes key figures such as Tyson Birchall and Art Robinson, who bring a wealth of knowledge and expertise to the firm.
Longbow Capital focuses on the energy sector, particularly the theme of energy transition. They partner with entrepreneurs and executives with significant industry expertise, offering both control and strategic minority investments. The firm currently manages the Longbow Energy Transition Fund and has committed over $1.4 billion in capital since its inception. Their investment strategy includes scaling businesses with established customer bases at pivotal points in growth, aiming to drive significant industry changes.
Notable investments by Longbow Capital include companies like Amped-Up - energy storage solutions, Lithion - advanced battery technologies, MissionESG - energy efficiency analytics, CLIR - clean energy solutions, Arcus - renewable energy infrastructure, and VoltGrid - smart grid technology. The firm prides itself on fostering strong partnerships and delivering exceptional outcomes for all stakeholders.
Longevity Ventures
Longevity Ventures is an investor focusing on breakthroughs in the field of longevity. Their headquarters are not explicitly listed on their site, but they are dedicated to supporting transformative companies in the longevity space. Details on their founding year, team composition, or what sets them apart are not available from the provided sources.
Longevity Ventures invests primarily in sectors related to health and longevity, including biotechnology and MedTech. The specific investment stages and geographic preferences are not mentioned on their website, but they maintain a portfolio of companies striving to extend human life through innovative solutions. Information regarding the firm's total assets under management or strategic partners is not available.
Their portfolio features companies like Senda - focused on biotechnology, Biolinq - working in health monitoring, LyGenesis - involved in organ regeneration, Laronde - specializing in therapeutic platforms, and 4DMT - innovating gene therapy solutions. Other notable companies include Tessera, Eko, Exo, Sigilon, Insilico, Freenome, and Valo, each contributing to the advancement of health and longevity technologies.
Longevity Vision Fund
Longevity Vision Fund is a venture capital firm based in New York, founded in 2019. The firm focuses on investing in technologies that aim to extend human lifespan and improve health. With a small team of professionals, they are dedicated to supporting breakthroughs in longevity and healthcare, distinguishing themselves by their commitment to making these advancements accessible and affordable.
The fund primarily invests in sectors such as preventive medicine, medical technologies, artificial intelligence in healthcare, longevity therapies, and regenerative medicine. They typically engage in Series A to C funding rounds, focusing on companies within the United States. Their portfolio includes investments in companies like Biolinq, Senda Biosciences, and Tessera Therapeutics. Longevity Vision Fund I, launched in 2020, manages assets worth $100 million.
Notable investments by Longevity Vision Fund include Biolinq - monitoring equipment, Senda Biosciences - biotechnology, Tessera Therapeutics - drug delivery, LyGenesis - drug discovery, and Eko - monitoring equipment. These companies reflect the fund's focus on innovative health technologies and longevity solutions.
Longitude Capital
Longitude Capital is a venture capital firm headquartered in Menlo Park, California, and Boston, Massachusetts. Founded by Juliet Bakker, Patrick Enright, and others with extensive experience in life sciences investing, the firm specializes in venture growth investments within the healthcare industry, particularly in biotechnology, medical technology, and health solutions. The team is comprised of seasoned investors with a cumulative investing history of over two centuries, having collaborated on numerous investments and exits. Their approach distinguishes them by focusing on clinically de-risked assets and employing a range of investment vehicles.
The firm invests in companies tackling various challenges in healthcare sectors such as biotechnology, medical technology, and health solutions. They target companies at both clinical and commercial stages, utilizing investment sizes adaptable to the venture growth strategy. Their geographic focus primarily lies in North America, boasting a total AUM of over $2 billion across six funds. Longitude Capital is known for its innovative investment strategies, including venture capital, asset spin-outs, and equity-linked instruments.
Notable investments by Longitude Capital include Axonics Modulation Technologies - neuromodulation devices, PROCEPT BioRobotics - robotic surgical systems, Jazz Pharmaceuticals - specialty pharmaceuticals, and Insulet - diabetes care technology. The firm has demonstrated a history of successful exits and liquidity events, leveraging its broad industry network and strategic partnerships.
LongJump
LongJump is a first-check, founder-led venture capital fund based in the Midwest, with a particular focus on Chicago. The firm is industry-agnostic and aims to support early-stage entrepreneurs in turning ambitious ideas into high-growth companies. Their team comprises of over 200 founders, operators, and investors, offering extensive networks and unique insights to startups in their portfolio.
LongJump typically invests $110,000 at the pre-seed stage, focusing on companies located in the Midwest. They are industry agnostic but emphasize geographic preference to support regional startups. The firm has made 45 investments, serving as the primary capital source for founders in the region. LongJump does not specify managing multiple funds or a total AUM on their site.
Notable investments include Avant Health, Eventnoire, DeepWalk Research, Evergreen, Bilin Academy, and Blip Energy. Each company represents diverse sectors such as healthcare, marketplaces, B2B SaaS, consumer e-commerce, edtech, and deep tech. The firm's emphasis is on being a genuine partner for founders, helping them navigate complex challenges from day one.
LongRange Capital
LongRange Capital is a private equity firm based in Stamford, Connecticut, founded in 2020. The firm is led by a team of 14 professionals and focuses on building stronger middle-market businesses through a long-term investment approach. They emphasize a company-focused and customer-first philosophy, offering flexible capital solutions that can be tailored to either majority or minority ownership positions.
The firm invests in sectors such as non-discretionary consumer products, value-added industries, and data & information-based services. LongRange Capital typically invests between $46 million and $363 million, targeting companies with revenues exceeding $182 million. Their investments are primarily in North America and Europe, with a total AUM of $1.8 billion.
Notable investments by LongRange Capital include Pizza Hut - a well-known restaurant chain, 24 Hour Fitness USA - a leisure facilities provider, US Synthetic - an oil and gas equipment company, Halcyon Death Care Management Solutions - a business productivity software provider, and Alpin Unlimited - a holding company.
Longship AS
Longship is a private equity investor targeting medium sized growth companies in Norway. The Longship fund is advised by Longship AS. Longship is established by four senior partners, who all have extensive background from private equity, and with a solid and demonstrated track record of delivering value to investors. Longship is partnering with owners and high calibre management teams in successful businesses. We support our investments with financial resources and experience, in order to accelerate growth and realize their full potential.
LongWall Ventures
Longwall Ventures manages three venture capital funds, investing in innovative, UK based, early stage companies in the healthcare, science and engineering sectors.
LongWater
LongWater is a private markets investment firm headquartered in Fargo, ND, Dallas, TX, and St. Louis, MO. Established in 2009, LongWater focuses exclusively on the lower middle market. The firm is managed by a team led by senior executives including Kevin Prunty and managing directors Trevor Gibson, Nick Careklas, Ben Dinehart, and Sam Panke. It differentiates itself by providing institutional-grade access to this market segment through two platforms: LongWater Private Equity and LongWater Capital Solutions.
LongWater invests in sectors such as industrials, leveraging a multi-faceted approach that includes private credit, minority equity, and LP commitments. Their target investment size ranges primarily from $10 million to $50 million, focusing on companies with strong fundamentals and growth potential within the United States. The firm currently manages about $1 billion in regulatory assets and has a diverse investor base including banks, family offices, and institutional investors.
Notable investments made by LongWater include Valley Lighting, a provider of commercial lighting and shading solutions, marking one of its key deployments from its SBIC fund. The firm's strategy revolves around non-control equity investments and strategic partnerships with private equity sponsors, aiming to provide flexible capital solutions in underserved markets.
Longwood Fund
Longwood Fund is a venture capital firm based in Boston, Massachusetts, known for creating and investing in science-driven companies addressing critical medical issues. The firm was co-founded by Christoph Westphal, who has a history of building and leading biotechnology firms. Longwood Fund operates with a team of seasoned professionals, often taking active roles in their portfolio companies, such as Co-Founding CEOs, CBOs, or Presidents.
The firm focuses on the healthcare sector, particularly in biotechnology and pharmaceuticals. Its investment strategy targets early-stage companies innovating in areas like novel therapeutics and medical technologies, primarily within North America. The firm does not publicly disclose its total assets under management.
Notable investments by Longwood Fund include Pyxis Oncology, Werewolf Therapeutics, TScan Therapeutics, and Pulmocide. These companies span innovative therapeutic development and biotechnologies. Additionally, Longwood Fund has been instrumental in co-founding significant ventures such as Immunitas Therapeutics and Be Biopharma.